Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

被引：0
作者：
Jérémie Sellam
Elodie Rivière
Alice Courties
Paul-Olivier Rouzaire
Barbara Tolusso
Edward M. Vital
Paul Emery
Gianfranco Ferraccioli
Martin Soubrier
Bineta Ly
Houria Hendel Chavez
Yassine Taoufik
Maxime Dougados
Xavier Mariette
机构：
[1] INSERM UMRS_938,Université Paris 06, AP
[2] Center for Immunology of Viral Infections and Autoimmune Diseases INSERM U1184,HP St
[3] Clermont-Ferrand University Hospital,Antoine hospital, Rheumatology Department
[4] Catholic University of the Sacred Heart,Université Paris
[5] NIHR Leeds Musculoskeletal Biomedical Research Unit,Sud, AP
[6] Leeds Teaching Hospitals NHS Trust,HP Hôpitaux Universitaires Paris
[7] Leeds,Sud, Rheumatology Department
[8] UK and Leeds Institute of Rheumatic and Musculoskeletal Medicine,Biological Immunology Department, ERTICa Research Group
[9] University of Leeds,Rheumatology Department
[10] Clermont-Ferrand University Hospital,Rheumatology Department
[11] INSERM U1184,AP
[12] Paris Descartes University,HP Bicêtre Hospital, Biological Immunology Department
[13] Assistance Publique - Hôpitaux de Paris,Department of Rheumatology
[14] INSERM (U1153), Hôpital Cochin
[15] Clinical Epidemiology and Biostatistics,undefined
[16] Service de Rhumatologie,undefined
[17] Hôpital de Bicêtre,undefined
[18] Service de Rhumatologie,undefined
[19] Hôpital Saint-Antoine,undefined
来源：
Arthritis Research & Therapy | / 18卷
关键词：
Rheumatoid arthritis; Interleukin 33; Rituximab; B-cell; Personalized medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 145 条
[1]  
Liew FY(2010)Disease-associated functions of IL-33: the new kid in the IL-1 family Nat Rev Immunol 10 103-10
[2]  
Pitman NI(2015)Targeting IL-33 in autoimmunity and inflammation J Pharmacol Exp Ther 354 24-31
[3]  
McInnes IB(2013)Alarmins in tendinopathy: unravelling new mechanisms in a common disease Rheumatol Oxf Engl 52 769-79
[4]  
Theoharides TC(2005)IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 479-90
[5]  
Petra AI(2010)IL-33 exacerbates eosinophil-mediated airway inflammation J Immunol Baltim Md 1950 185 3472-80
[6]  
Taracanova A(2008)IL-33 exacerbates antigen-induced arthritis by activating mast cells Proc Natl Acad Sci U S A 105 10913-8
[7]  
Panagiotidou S(2010)IL-33 exacerbates autoantibody-induced arthritis J Immunol 184 2620-6
[8]  
Conti P(2016)Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33 Arthritis Res Ther 18 143-40
[9]  
Millar NL(2012)IL-33 regulates TNF-α dependent effects in synovial fibroblasts Int J Mol Med 29 530-75
[10]  
Murrell GAC(2015)IL-33 exacerbates periodontal disease through induction of RANKL J Dent Res 94 968-43
12345678910